| [1] |
Lukashev AN, Ivanova OE, Eremeeva TP, et al. Evidence of frequent recombination among human adenoviruses[J]. J Gen Virol, 2008,89(2):380-388.
doi: 10.1099/vir.0.83057-0
URL
|
| [2] |
王美华, 缑朝云. 解析与肿瘤密切相关的病毒[J]. 抗癌之窗, 2013, (6):23-25.
|
| [3] |
Khanal S, Ghimire P, Dhamoon AS. The repertoire of adenovirus in human disease: The innocuous to the deadly[J]. Biomedicines, 2018,6(1):30.
doi: 10.3390/biomedicines6010030
URL
|
| [4] |
Romanowski EG, Gordon YJ. Efficacy of topical cidofovir on multiple adenoviral serotypes in the New Zealand rabbit ocular model[J]. Invest Ophthalmol Vis Sci, 2000,41(2):460-463.
|
| [5] |
Ganapathi L, Arnold A, Jones S, et al. Use of cidofovir in pediatric patients with adenovirus infection[J]. F1000Res, 2016,5:758.
doi: 10.12688/f1000research.8374.1
pmid: 27239277
|
| [6] |
窦唱, 李兴旺. 社区获得性病毒性肺炎病原学治疗研究进展[J]. 中国病毒病杂志, 2018,8(5):421-426.
|
| [7] |
Ying B, Tollefson AE, Spencer JF, et al. Ganciclovir inhibits human adenovirus replication and pathogenicity in permissive immunosuppressed Syrian hamsters[J]. Antimicrob Agents Chemother, 2014,58(12):7171-7181.
doi: 10.1128/AAC.03860-14
URL
|
| [8] |
Yoon BW, Song YG, Lee SH. Severe community-acquired adenovirus pneumonia treated with oral ribavirin: A case report[J]. BMC Res Notes, 2017,10(1):47.
doi: 10.1186/s13104-016-2370-2
URL
|
| [9] |
Toth K, Hussein ITM, Tollefson AE, et al. Filociclovir is a potent in vitro and in vivo inhibitor of human adenoviruses[J]. Antimicrob Agents Chemother, 2020,64(11):e01299-e01320.
|
| [10] |
Naesens L, Lenaerts L, Andrei G, et al. Antiadenovirus activities of several classes of nucleoside and nucleotide analogues[J]. Antimicrob Agents Chemother, 2005,49(3):1010-1016.
pmid: 15728896
|
| [11] |
Saha B, Varette O, Stanford WL, et al. Development of a novel screening platform for the identification of small molecule inhibitors of human adenovirus[J]. Virology, 2019,538:24-34.
doi: 10.1016/j.virol.2019.09.005
URL
|
| [12] |
Hsu E, Pennella MA, Zemke NR, et al. Adenovirus E1A activation domain regulates H3 acetylation affecting varied steps in transcription at different viral promoters[J]. J Virol, 2018,92(18):e00805-e00818.
|
| [13] |
Tsai K, Cullen BR. Epigenetic and epitranscriptomic regulation of viral replication[J]. Nat Rev Microbiol, 2020,18(10):559-570.
doi: 10.1038/s41579-020-0382-3
URL
|
| [14] |
Saha B, Parks RJ. Histone deacetylase inhibitor suberoylanilide hydroxamic acid suppresses human adenovirus gene expression and replication[J]. J Virol, 2019,93(12):e00088-e00119.
|
| [15] |
Arbuckle JH, Gardina PJ, Gordon DN, et al. Inhibitors of the histone methyltransferases EZH2/1 induce a potent antiviral state and suppress infection by diverse viral pathogens[J]. mBio, 2017,8(4):e01141-e01117.
|
| [16] |
Saha B, Parks RJ. Identification of human adenovirus replication inhibitors from a library of small molecules targeting cellular epigenetic regulators[J]. Virology, 2021,555:102-110.
doi: 10.1016/j.virol.2020.07.007
URL
|
| [17] |
Grosso F, Stoilov P, Lingwood C, et al. Suppression of adenovirus replication by cardiotonic steroids[J]. J Virol, 2017,91(3):e01623-e01716.
|
| [18] |
Amarelle L, Lecuona E. The antiviral effects of Na, K-ATPase inhibition: A minireview[J]. Int J Mol Sci, 2018,19(8):2154.
doi: 10.3390/ijms19082154
URL
|
| [19] |
Marrugal-Lorenzo JA, Serna-Gallego A, González-González L, et al. Inhibition of adenovirus infection by mifepristone[J]. Antiviral Res, 2018,159:77-83.
doi: 10.1016/j.antiviral.2018.09.011
URL
|
| [20] |
Sánchez-Céspedes J, Martínez-Aguado P, Vega-Holm M, et al. New 4-Acyl-1-phenylaminocarbonyl-2-phenylpiperazine derivatives as potential inhibitors of adenovirus infection. Synjournal, biological evaluation, and structure-activity relationships[J]. J Med Chem, 2016,59(11):5432-5448.
doi: 10.1021/acs.jmedchem.6b00300
pmid: 27195951
|
| [21] |
Georgi F, Andriasyan V, Witte R, et al. The FDA-approved drug nelfinavir inhibits lytic cell-free but not cell-associated nonlytic transmission of human adenovirus[J]. Antimicrob Agents Chemother, 2020,64(9):e01002- e01020.
|
| [22] |
Wang X, Zhang Q, Zhou Z, et al. Retinoic acid receptor β, a potential therapeutic target in the inhibition of adenovirus replication[J]. Antiviral Res, 2018,152:84-93.
doi: 10.1016/j.antiviral.2018.01.014
URL
|
| [23] |
King CR, Tessier TM, Dodge MJ, et al. Inhibition of human adenovirus replication by the importin α/β1 nuclear import inhibitor ivermectin[J]. J Virol, 2020,94(18):e00710-e00720.
|
| [24] |
王静凛. 丙种球蛋白联合抗感染佐治小儿重症腺病毒肺炎的临床疗效[J]. 中国药物经济学, 2019,14(7):51-54.
|
| [25] |
Abraham AA, John TD, Keller MD, et al. Safety and feasibility of virus-specific T cells derived from umbilical cord blood in cord blood transplant recipients[J]. Blood Adv, 2019,3(14):2057-2068.
doi: 10.1182/bloodadvances.2019000201
URL
|
| [26] |
Clement C, Capriotti JA, Kumar M, et al. Clinical and antiviral efficacy of an ophthalmic formulation of dexamethasone povidone-iodine in a rabbit model of adenoviral keratoconjunctivitis[J]. Invest Ophthalmol Vis Sci, 2011,52(1):339-344.
doi: 10.1167/iovs.10-5944
URL
|
| [27] |
Toth K, Spencer JF, Dhar D, et al. Hexadecyloxypropyl-cidofovir, CMX001, prevents adenovirus-induced mortality in a permissive, immunosuppressed animal model[J]. Proc Natl Acad Sci U S A, 2008,105(20):7293-7297.
doi: 10.1073/pnas.0800200105
URL
|
| [28] |
Wold WSM, Tollefson AE, Ying B, et al. Drug development against human adenoviruses and its advancement by Syrian hamster models[J]. FEMS Microbiol Rev, 2019,43(4):380-388.
doi: 10.1093/femsre/fuz008
URL
|
| [29] |
Hartline CB, Keith KA, Eagar J, et al. A standardized approach to the evaluation of antivirals against DNA viruses: Orthopox-, adeno-, and herpesviruses[J]. Antiviral Res, 2018,159:104-112.
doi: 10.1016/j.antiviral.2018.09.015
URL
|
